NovaCardia Presents Phase II Data for KW-3902 at American Heart Assoc's 79th Annual Scientific Sessions
14th Nov 2006, 23:24 GMT
NovaCardia announced that results from Phase II clinical trials of KW-3902, an adenosine A1 receptor antagonist in development for the treatment of congestive heart failure, were presented in 2 sessions at the American Heart Assoc's 79th Annual Scientific Sessions in Chicago, IL.
NovaCardia Presents Phase II Data for KW-3902 at American Heart Assoc's 79th Annual Scientific Sessions related news:
- - Webcast Alert: Isis Pharmaceuticals Announces Its Analyst/Investor Webcast Presentation — Partnerships/ Joint Ventures News from StratCenter.com
- Treatment of Diabetic Foot Ulcers Addressed at Upcoming American Heart Assoc Meeting — Nephrology/ Dialysis News from StratCenter.com
- New Data on Otsuka's Investigational Product for Hyponatremia Presented at American Heart Assoc Annual Meeting — Pharmaceuticals News from StratCenter.com
- Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting — Partnerships/ Joint Ventures News from StratCenter.com
- First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits — ArriveNet : Press Releases
- New data show ACTOS (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT — EurekAlert! - Medicine and Health
- Schering-Plough CEO Calls on New Congress to 'Do What Is Right' for the Patient, Calls for 'Scorecards' to Rate Managed Care Performance — Government/ Industry Regulation News from StratCenter.com
- Scientific American names UCSB professor, alumna to list of Top 50 in Technological Leadership — EurekAlert! - Technology, Engineering and Computer Science
- Columbia scientists present research findings at AHA Scientific Sessions — EurekAlert! - Medicine and Health
- Long-Term Data Shows No Increase In Cancer Cases From Biologic Therapy — Health News from Medical News Today
Latest news from Nephrology/ Dialysis News from StratCenter.com:
- New Data Show ACTOS Halted Progression of Atherosclerosis as Indicated by CIMT in Patients with Type 2 Diabetes
- Ruboxistaurin Reduced Vision Loss in Patients With Moderate to Severe Non-Proliferative Diabetic Retinopathy in a New Study
- Aksys Reports Q3 2006 Financial Results
- Altus Pharmaceuticals Announces Presentation of ALTU-238 Phase II Data at Int'l Congress of Growth Hormone and Insulin-Like Growth Factor Research Societies
- Opexa Reports Q3 Financial Results
- Treatment of Diabetic Foot Ulcers Addressed at Upcoming American Heart Assoc Meeting
- Weight Loss Surgery Assists in Eliminating, Avoiding Type 2 Diabetes; American Institute of Gastric Banding Recognizes November as Nat'l Diabetes Month
- Federal Economic Development Agency Enlists Support of African-American Churches in the IL Delta
- Federal Economic Development Agency Enlists Support of African-American Churches in the MS Delta
- Federal Economic Development Agency Enlists Support of African-American Churches in the LA Delta